, Tracking Stock Market Picks
Enter Symbol:
Array Biopharma Inc. (ARRY) [hlAlert]

down 6.41 %

Array Biopharma Inc. (ARRY) rated Buy with price target $9 by Stifel

Posted on: Monday,  Jan 26, 2015  8:25 AM ET by Stifel

Stifel rated Buy Array Biopharma Inc. (NASDAQ: ARRY) on 01/26/2015. Previously Stifel rated Buy Array Biopharma Inc. (NASDAQ: ARRY) on 08/09/2013.,
when the stock price was $6.24. Since then, Array Biopharma Inc. has lost 6.41% as of 01/15/2016's recent price of $5.84.
If you would have followed the previous Stifel's recommendation on ARRY, you would have lost 6.41% of your investment in 889 days.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. The company's proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/26/2015 8:25 AM Buy
6.93 9.00
as of 8/27/2015
1 Week up  2.09 %
1 Month down  -26.07 %
3 Months down  -18.88 %
1 YTD up  16.56 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/9/2013 9:25 AM Buy
6.24 8.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy